You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Bacterial infections Mikapime 125 mg/500 mg Injection kills the bacteria which can cause serious infections. It is given by a doctor or nurse into a vein and should not be self-administered. Mikapime 125 mg/500 mg Injection usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Mikapime 125 mg/500 mg Injection is a combination of two medicines: Amikacin and Cefepime. Amikacin is an antibiotic which stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions. Cefepime is also an antibiotic which works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Together, they eradicate your infection effectively.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Mikapime 125 mg/500 mg Injection .
Seek medical advice from your doctor: Mikapime 125 mg/500 mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Safe when prescribed by an expert: Mikapime 125 mg/500 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Mikapime 125 mg/500 mg Injection, since it may have possible effects such as rash and diarrhea.
Not Safe: Mikapime 125 mg/500 mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Mikapime 125 mg/500 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Mikapime 125 mg/500 mg Injection may be needed. Doctor consultation is advised.
Safe when prescribed by an expert: Mikapime 125 mg/500 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mikapime 125 mg/500 mg Injection may not be needed in these patients. Doctor consultation is advised.
If a dose of Mikapime 125 mg/500 mg Injection is missed, it's advisable to consult your doctor.
Alembic Road, Vadodara - 390 003, Gujarat,INDIA
Venus Remedies Limited. Amikacin + Cefepime (08 Apr. 2019)
Amikacin sulfate. Hurley, Maidenhead: Hospira UK Limited; 1996 (08 Apr. 2019)
Cefepime. Deerfield, Illinois: Baxter Healthcare Corporation; 1996 (08 Apr. 2019)
Amikacin (10 Oct. 2023)
Cefepime (08 Apr. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.